nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered membrane fluidity and lipid raft composition in presenilin-deficient cells
|
Grimm, M. O. W. |
|
2006 |
114 |
s185 |
p. 27-32 |
artikel |
2 |
Alzheimer's Disease: back to the future
|
Kivipelto, M. |
|
2006 |
114 |
s185 |
p. 119-120 |
artikel |
3 |
Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology
|
Mahley, R. W. |
|
2006 |
114 |
s185 |
p. 8-14 |
artikel |
4 |
Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease
|
Laskowitz, D. T. |
|
2006 |
114 |
s185 |
p. 15-20 |
artikel |
5 |
Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence
|
Kivipelto, M. |
|
2006 |
114 |
s185 |
p. 50-57 |
artikel |
6 |
Cholesterol metabolism in the brain: importance of 24S-hydroxylation
|
Lütjohann, D. |
|
2006 |
114 |
s185 |
p. 33-42 |
artikel |
7 |
Cholesterol, statins and tau
|
Ohm, T. G. |
|
2006 |
114 |
s185 |
p. 93-101 |
artikel |
8 |
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
|
Sparks, D. L. |
|
2006 |
114 |
s185 |
p. 3-7 |
artikel |
9 |
Effect of statins on β-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease
|
Höglund, K. |
|
2006 |
114 |
s185 |
p. 87-92 |
artikel |
10 |
Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease
|
Rockwood, K. |
|
2006 |
114 |
s185 |
p. 71-77 |
artikel |
11 |
Inflammation and dementia: epidemiologic evidence
|
Peila, R. |
|
2006 |
114 |
s185 |
p. 102-106 |
artikel |
12 |
In vivo evidence for microglial activation in neurodegenerative dementia
|
Cagnin, A. |
|
2006 |
114 |
s185 |
p. 107-114 |
artikel |
13 |
Oxysterols and Alzheimer's disease
|
Björkhem, I. |
|
2006 |
114 |
s185 |
p. 43-49 |
artikel |
14 |
Re-assessing the relationship between cholesterol, statins and Alzheimer's disease
|
Wolozin, B. |
|
2006 |
114 |
s185 |
p. 63-70 |
artikel |
15 |
Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
|
Michikawa, M. |
|
2006 |
114 |
s185 |
p. 21-26 |
artikel |
16 |
Statin therapy in Alzheimer's disease
|
Sparks, D. L. |
|
2006 |
114 |
s185 |
p. 78-86 |
artikel |
17 |
The lower the better? Experiences from cardiovascular disease and stroke prevention
|
Olsson, A. G. |
|
2006 |
114 |
s185 |
p. 58-62 |
artikel |
18 |
The new cholesterol controversy – a little bit of history repeating?
|
|
|
2006 |
114 |
s185 |
p. 1-2 |
artikel |
19 |
The role of pleiotropic effects of statins in dementia
|
Crisby, M. |
|
2006 |
114 |
s185 |
p. 115-118 |
artikel |